Flexion Therapeutics Inc (FLXN:NASDAQ) Investor Relations Material

Overview

Flexion Therapeutics is a company that specializes in creating pharmaceutical products to help patients with musculoskeletal conditions. Their focus is on developing anti-inflammatory and analgesic therapies to help ease patients' pain and improve their quality of life. Flexion Therapeutics has made significant progress in this field, and Wall Street Journal journalists consider them to be one of the leading companies in the industry. With a strong commitment to research and development, Flexion Therapeutics is well-positioned to continue creating innovative solutions to help patients in need.

Frequently Asked Questions

What is Flexion Therapeutics Inc's ticker?

Flexion Therapeutics Inc's ticker is FLXN

What exchange is Flexion Therapeutics Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Flexion Therapeutics Inc's headquarters?

They are based in Burlington, Massachusetts

How many employees does Flexion Therapeutics Inc have?

There are 51-200 employees working at Flexion Therapeutics Inc

What is Flexion Therapeutics Inc's website?

It is http://flexiontherapeutics.com/

What type of sector is Flexion Therapeutics Inc?

Flexion Therapeutics Inc is in the Healthcare sector

What type of industry is Flexion Therapeutics Inc?

Flexion Therapeutics Inc is in the Drugs - Generic industry

Who are Flexion Therapeutics Inc's peers and competitors?

The following five companies are Flexion Therapeutics Inc's industry peers:

- Ironwood Pharmaceuticals

- Catalent

- Sophiris Bio Inc.

- Mallinckrodt

- Horizon Therapeutics Public Company